1. Home
  2. CELU

CELU

Celularity Inc.

Logo Celularity Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases.

Founded: 2016 Country:
United States
United States
Employees: 225 City: FLORHAM PARK
Market Cap: 66.0M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 105.1K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -10.20 EPS Growth: N/A
52 Week Low/High: $1.59 - $8.90 Next Earning Date: 05-20-2024
Revenue: $14,788,000 Revenue Growth: -20.93%
Revenue Growth (this year): 255.59% Revenue Growth (next year): -68.68%

Share on Social Networks: